| Mrs Pamela L Keup, SLP | |
|
Psc 561 Box 1546, Fpo, AP 96310 | |
| (011) 818-2779 | |
| Not Available |
| Full Name | Mrs Pamela L Keup |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Psc 561 Box 1546, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952433245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP 4324 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela L Keup, SLP Psc 561 Box 1546, Fpo, AP 96310 Ph: (011) 818-2779 | Mrs Pamela L Keup, SLP Psc 561 Box 1546, Fpo, AP 96310 Ph: (011) 818-2779 |
News Archive
A study to determine if patients with type 2 diabetes can benefit from a combination of autologous (patient self-donated) stem cell infusions (ASC) and hyperbaric (above the normal air pressure of ) oxygen treatment (HBO) before and after ASC has found "significant benefits" in terms of "improvements in glycemic control" along with "reduced insulin requirements."
Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) extended-cycle oral contraceptive product, prior to the expiration of patents owned by Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc.
Inter Press Service examines the possibility of another U.N. conference on development and population within the next five years. Despite progress made since the 1994 conference on population and development (ICPD), U.N. Secretary-General Ban Ki-Moon recently noted more than 200 million women cannot access safe and effective contraception, and "too many women resort to unsafe abortions because they lack access to family planning," according to the news service.
In a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for early-stage Huntington's disease, a neurodegenerative disorder that attacks brain cells.
› Verified 9 days ago
Ms. Holly Eun Hee Gangwer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 561 Box 1877, Fpo, AP 96310 Phone: 011-827-794180 | |
Kati Conners, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 334-819-9511 | |
Mrs. Kristin Rachel Blake, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 1600, Fpo, AP 96367 Phone: 011-816-117342747 | |
Mrs. Paige Christine Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6162d- Camp Lester, Fpo, AP 96362 Phone: 011-816-117468093 | |
Barbara Jean Neal, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 Phone: 011-814-68165564 Fax: 011-814-68168650 | |
Ms. Edna E. Nyang, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 611-646-7723 | |
Kimberly Lowery, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 215-264-3402 |